Recent Updates
Recently added Catalysts
QDEL Positive Sentiment

Science Bytes Podcast Explores How Diagnostics Can Help Protect Students and Communities With classrooms once again filled and respiratory virus season beginning, QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro...

Thursday, August 21, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: QuidelOrtho Corporation is addressing public health concerns as schools reopen and respiratory virus season approaches. The company is sharing insights from Dr. Jonathan Temte, a respected expert in family medicine and community health. This initiative aims to inform and protect students and communities during this critical time.
Price reaction · baseline $26.34 (2025-08-20 close) · hit after-hours · clean, no other QDEL news in the window
day 0 close · peak
-2.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • QuidelOrtho is providing valuable public health insights.
  • The podcast addresses timely issues related to respiratory viruses.
  • Engagement with experts like Dr. Jonathan Temte enhances credibility.

Full Press Release Details

SAN DIEGO,Aug. 21, 2025/PRNewswire/ -- With classrooms once again filled and respiratory virus season beginning, QuidelOrtho Corporation (Nasdaq:QDEL), a global leader of in vitro diagnostics, is sharing timely public health insights from Dr.Jonathan Temte, Professor of Family Medicine and Community Health at theUniversity of Wisconsin-Madison.

Frequently Asked Questions

What is the focus of QuidelOrtho's podcast?

The podcast focuses on how diagnostics can help protect students and communities.

Who is Dr. Jonathan Temte?

Dr. Jonathan Temte is a Professor of Family Medicine and Community Health at UW-Madison.

Why is the podcast timely?

It addresses public health insights as schools reopen and respiratory virus season starts.

What is QuidelOrtho's role in diagnostics?

QuidelOrtho is a global leader in in vitro diagnostics.

ShareAdd on Google
Tags: QDEL Viatris Investor Conferences Healthcare QuidelOrtho diagnostics respiratory viruses public health Dr. Jonathan Temte
Last updated: Aug 21, 2025

Biotech snapshot

Cash runway
$123M liquidity · $7M/mo burn
~17 mo
Low dilution risk